Perachino, M. and Eandi, M. (2013) “The utility of a model-based cost-effectiveness analysis of degarelix versus leuprolide in the therapy of hormone-dependent advanced prostate cancer”, Farmeconomia. Health economics and therapeutic pathways, 14(3), pp. 131–146. doi: 10.7175/fe.v14i3.700.